Search
Now showing items 1-10 of 11
Nucleic acid encoding feline CD86
(United States. Patent and Trademark Office, 2006-07-18)
The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
MHC II analog from Staphylococcus aureus
(United States. Patent and Trademark Office, 1997-07-15)
Staphylococcus aureus can bind a number of different extracellular matrix proteins. Recent studies have shown that one particular Staphylococcus protein has the capacity of binding several different matrix proteins. The ...
Microorganisms and methods for overproduction of DAHP by cloned Pps gene
(United States. Patent and Trademark Office, 2007-05-29)
Genetic elements comprising expression vectors and a gene coding for phosphoenol pyruvate synthase is utilized to enhance diversion of carbon resources into the common aromatic pathway and pathways branching therefrom. The ...
Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms
(United States. Patent and Trademark Office, 1993-06-22)
A host microorganism is genetically and stably modified by the insertion into any of its non-essential chromosomal location of a non-homologous, recombinant foreign DNA fragment, maintaining an insertion of a luxAB gene ...
Polypeptides and polynucleotides from coagulase-negative staphylococci
(United States. Patent and Trademark Office, 2003-10-21)
Isolated proteins, designated SdrF, SdrG and SdrH, and their corresponding amino acid and nucleic acid sequences are provided which are useful in the prevention and treatment of infection caused by coagulase-negative ...
Compositions, organisms, systems, and methods for expressing a gene product in plants using SCBV expression control sequences operable in monocots and dicots
(United States. Patent and Trademark Office, 2014-04-29)
The present disclosure relates, in some embodiments, to compositions, organisms, systems, and methods for expressing a gene product in a plant using a expression control sequence (ECS) operable in monocots and/or dicots. ...
Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots
(United States. Patent and Trademark Office, 2008-01-29)
The invention is directed to isolated promoters from stem-regulated, defense-inducible genes, such as OMT promoters. The promoters are useful in expression cassettes and expression vectors for the transformation of plants. ...
DNA encoding Actinobacillus pleuropneumoniae hemolysin
(United States. Patent and Trademark Office, 1997-06-24)
This invention discloses the DNA sequences coding for the Actinobacillus pleuropneumonia hemolysin(s). It further discloses a method of producing the A. pleuropneumoniae hemolysin(s) from recombinant cells. It also provides ...
Oral immunization with transgenic plants
(United States. Patent and Trademark Office, 2001-02-27)
The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic plants and then administered through the consumption of the transgenic plant. DNA sequences both natural and synthetic encoding ...
DbpA compositions and methods of use
(United States. Patent and Trademark Office, 2001-11-06)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...